China Neuromodulation Market (2025-2031) | Share, Segmentation, Competitive Landscape, Industry, Value, Size & Revenue, Outlook, Forecast, Companies, Analysis, Growth, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Neuromodulation Market Revenues & Volume, 2021 & 2031F

3.3 China Neuromodulation Market - Industry Life Cycle

3.4 China Neuromodulation Market - Porter's Five Forces

3.5 China Neuromodulation Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 China Neuromodulation Market Revenues & Volume Share, By Biomaterial, 2021 & 2031F

3.7 China Neuromodulation Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of neurological disorders in China

4.2.2 Growing aging population in China leading to higher demand for neuromodulation therapies

4.2.3 Technological advancements in neuromodulation devices improving treatment outcomes

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of neuromodulation devices in China

4.3.2 Limited awareness and acceptance of neuromodulation therapies among healthcare providers and patients

4.3.3 High cost associated with neuromodulation treatments hindering market growth

6.1 China Neuromodulation Market, By Technology

6.1.1 Overview and Analysis

6.1.2 China Neuromodulation Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 China Neuromodulation Market Revenues & Volume, By Internal Neuromodulation, 2021- 2031F

6.1.4 China Neuromodulation Market Revenues & Volume, By External Neuromodulation, 2021- 2031F

6.2 China Neuromodulation Market, By Biomaterial

6.2.1 Overview and Analysis

6.2.2 China Neuromodulation Market Revenues & Volume, By Metallic Biomaterials, 2021- 2031F

6.2.3 China Neuromodulation Market Revenues & Volume, By Polymeric Biomaterials, 2021- 2031F

6.2.4 China Neuromodulation Market Revenues & Volume, By Ceramic Biomaterials, 2021- 2031F

6.3 China Neuromodulation Market, By Application

6.3.1 Overview and Analysis

6.3.2 China Neuromodulation Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F

6.3.3 China Neuromodulation Market Revenues & Volume, By Epilepsy, 2021- 2031F

6.3.4 China Neuromodulation Market Revenues & Volume, By Depression, 2021- 2031F

6.3.5 China Neuromodulation Market Revenues & Volume, By Dystonia, 2021- 2031F

6.3.6 China Neuromodulation Market Revenues & Volume, By Pain Management, 2021- 2031F

6.3.7 China Neuromodulation Market Revenues & Volume, By Others, 2021- 2031F

7.1 China Neuromodulation Market Export to Major Countries

7.2 China Neuromodulation Market Imports from Major Countries

8.1 Adoption rate of neuromodulation therapies in China

8.2 Number of clinical trials and research studies on neuromodulation in China

8.3 Investment in RD for developing innovative neuromodulation devices in China

9.1 China Neuromodulation Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 China Neuromodulation Market Opportunity Assessment, By Biomaterial, 2021 & 2031F

9.3 China Neuromodulation Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 China Neuromodulation Market Revenue Share, By Companies, 2024

10.2 China Neuromodulation Market Competitive Benchmarking, By Operating and Technical Parameters